A pragmatic dose-finding approach using short-term surrogate efficacy outcomes to evaluate binary efficacy and toxicity outcomes in phase I cancer clinical trials-Reference-Cited by-同舟云学术

A pragmatic dose-finding approach using short-term surrogate efficacy outcomes to evaluate binary efficacy and toxicity outcomes in phase I cancer clinical trials

Published:2013-08-23 Issue:5 Volume:12 Page:315-327
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceut. Statist.

Author:

Asakawa Takashi¹,Hamada Chikuma²

Affiliation:

1. Clinical Research Planning Department; Chugai Pharmaceutical Co., Ltd.; Tokyo; Japan

2. Faculty of Engineering; Tokyo University of Science; Tokyo; Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference17 articles.

1. Continual reassessment method: a practical design for phase I clinical trials in cancer;O'Quigley;Biometrics,1990

2. Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study;O'Quigley;Statistics in Medicine,1991

3. The continual reassessment method in cancer phase I clinical trials: a simulation study;Chevret;Statistics in Medicine,1993

4. Practical modifications of the continual reassessment method for phase I cancer clinical trials;Faries;Journal of Biopharmaceutical Statistics,1993

5. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;European Journal of Cancer,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian Predictive Probability Based on a Bivariate Index Vector for Single‐Arm Phase II Study With Binary Efficacy and Safety Endpoints;Pharmaceutical Statistics;2024-08-13

2. Bayesian optimization design for dose‐finding based on toxicity and efficacy outcomes in phase I/ II clinical trials;Pharmaceutical Statistics;2020-11-30

3. Early phase dose‐finding trials in virology;Statistics in Medicine;2020-10-14

4. Early Phase Clinical Trial Designs – State of Play and Adapting for the Future;Clinical Oncology;2017-12

5. Phase I/II Dose-Finding Designs with Efficacy and Safety Endpoints;Handbook of Methods for Designing, Monitoring, and Analyzing Dose-Finding Trials;2017-04-27